Literature DB >> 9846875

Iron center, substrate recognition and mechanism of peptide deformylase.

A Becker1, I Schlichting, W Kabsch, D Groche, S Schultz, A F Wagner.   

Abstract

Eubacterial proteins are synthesized with a formyl group at the N-terminus which is hydrolytically removed from the nascent chain by the mononuclear iron enzyme peptide deformylase. Catalytic efficiency strongly depends on the identity of the bound metal. We have determined by X-ray crystallography the Fe2+, Ni2+ and Zn2+ forms of the Escherichia coli enzyme and a structure in complex with the reaction product Met-Ala-Ser. The structure of the complex, with the tripeptide bound at the active site, suggests detailed models for the mechanism of substrate recognition and catalysis. Differences of the protein structures due to the identity of the bound metal are extremely small and account only for the observation that Zn2+ binds more tightly than Fe2+ or Ni2+. The striking loss of catalytic activity of the Zn2+ form could be caused by its reluctance to change between tetrahedral and five-fold metal coordination believed to occur during catalysis. N-terminal formylation and subsequent deformylation

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846875     DOI: 10.1038/4162

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  38 in total

1.  Thermolysin and mitochondrial processing peptidase: how far structure-functional convergence goes.

Authors:  K S Makarova; N V Grishin
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 2.  Synthetic analogues of cysteinate-ligated non-heme iron and non-corrinoid cobalt enzymes.

Authors:  Julie A Kovacs
Journal:  Chem Rev       Date:  2004-02       Impact factor: 60.622

Review 3.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

4.  Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.

Authors:  J M Clements; R P Beckett; A Brown; G Catlin; M Lobell; S Palan; W Thomas; M Whittaker; S Wood; S Salama; P J Baker; H F Rodgers; V Barynin; D W Rice; M G Hunter
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

5.  Structure and activity of human mitochondrial peptide deformylase, a novel cancer target.

Authors:  Sindy Escobar-Alvarez; Yehuda Goldgur; Guangli Yang; Ouathek Ouerfelli; Yueming Li; David A Scheinberg
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

6.  Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.

Authors:  Kathrine J Smith; Chantal M Petit; Kelly Aubart; Martin Smyth; Edward McManus; Jo Jones; Andrew Fosberry; Ceri Lewis; Michael Lonetto; Siegfried B Christensen
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

7.  Expression, crystallization and preliminary X-ray crystallographic analysis of peptide deformylase from Xanthomonas oryzae pv. oryzae.

Authors:  Phuong-Thuy Ho Ngo; Jin-Kwang Kim; Hyesoon Kim; Junho Jung; Yeh-Jin Ahn; Jeong-Gu Kim; Byoung-Moo Lee; Lin-Woo Kang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-28

Review 8.  The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium.

Authors:  James A Imlay
Journal:  Nat Rev Microbiol       Date:  2013-05-28       Impact factor: 60.633

9.  Ligand-induced changes in the structure and dynamics of Escherichia coli peptide deformylase.

Authors:  Carlos D Amero; Douglas W Byerly; Craig A McElroy; Amber Simmons; Mark P Foster
Journal:  Biochemistry       Date:  2009-08-18       Impact factor: 3.162

10.  Effect of metal binding and posttranslational lysine carboxylation on the activity of recombinant hydantoinase.

Authors:  Cheng-Yang Huang; Ching-Chen Hsu; Mei-Chun Chen; Yuh-Shyong Yang
Journal:  J Biol Inorg Chem       Date:  2008-09-10       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.